Cryptocurrency & Digital Assets

Island Way launches Lemonade Bites & Chocolate Covered Fruit, tripling its store count to 10,000 and targeting 50% revenue growth in a bold market move.

As federal funding for psychedelic therapy surges, practitioners warn that a critical lack of patient preparation and integration support could undermine healing.

A $33M C-PACE deal for a Deepak Chopra-affiliated resort shows how innovative financing is reshaping real estate development in a tight market.

As consumers seek healthier energy, a new sublingual powder promises a fast, crash-free boost, challenging the dominance of coffee and energy drinks.

A new firm will underwrite a $400M fund, signaling a shift in patent finance toward specialized expertise and empowering small inventors.

Xali Gold is advancing its Pico Machay project in Peru, where vast gold potential at historically low prices meets a notoriously tough regulatory landscape.

Giyani Metals' high-purity manganese meets quality standards from US tech leader C4V, a crucial step in building a non-Chinese battery supply chain.

PowerBank's new 4.99 MW battery in Cramahe is online, boasting a lucrative 22-year contract and a groundbreaking 50% First Nations ownership stake.

A new drug, CS-1103, earns FDA Fast Track to combat fentanyl overdoses by binding and removing the opioid, a potential game-changer over naloxone.

Fintech leader Questrade is launching Questbank, a new digital bank aiming to disrupt the market with modern tech and a focus on everyday banking.

A new report reveals U.S. firms lead in security spending intent but lag in AI deployment, creating a dangerous gap between belief and reality.

A new report finds over 80% of Canada's foundational forage fish stocks are unhealthy, threatening marine life and a multi-billion-dollar ocean economy.

The new Spring 2026 platform moves beyond data storage, using AI to transform MedTech regulatory affairs into a strategic, high-speed execution engine.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.

Amid record-breaking sales, Acker launches a major Singapore auction and retail platform, betting on a new generation of digitally savvy Asian collectors.

As Strauss Group prepares its Q1 2026 results, investors are watching to see if strong 2025 momentum can overcome inflation and market shifts.

The clean energy vehicle company is assembling a top-tier team to develop hydrogen-powered drones, aiming for a slice of the $182 billion UGV market.

Meren Energy's upcoming Q1 2026 results will be scrutinized for its performance in Africa's deepwater projects amidst soaring oil prices and strategic shifts.

Anomali's new platform uses 'agentic AI' to automate cyber defense decisions, promising a 300x speed boost. But can it deliver on its ambitious vision?

Beyond its first blockbuster, CRISPR Therapeutics reveals a deep pipeline for autoimmune and liver diseases, backed by a strong Q1 balance sheet.